CN Patent

CN1528326A — 主治痤疮的复方外用药物

Assigned to INSTITUTE OF DERMATOLOGY CHINESE ACADEMY OF MEDICAL SCIENCES · Expires 2004-09-15 · 22y expired

What this patent protects

本发明涉及一种主治痤疮的复方外用药物。其特征在于：复方外用药物的基质载体中含有下列有效活性成分(重量百分比)：阿达帕林0.01～2％，抗菌药0.25～5％。本发明的优点在于：本发明是以复方制剂形式包含维A酸类及抗菌类两类治疗痤疮的主成分，以同时发挥3种(及以上)的疗效作用(溶解角栓、调节角化、抗微生物、抗炎症、减轻皮脂分泌的继发因素等)在药理学上发挥了互补及协同作用，使治疗作用更全面、深入，疗效更满意。

USPTO Abstract

本发明涉及一种主治痤疮的复方外用药物。其特征在于：复方外用药物的基质载体中含有下列有效活性成分(重量百分比)：阿达帕林0.01～2％，抗菌药0.25～5％。本发明的优点在于：本发明是以复方制剂形式包含维A酸类及抗菌类两类治疗痤疮的主成分，以同时发挥3种(及以上)的疗效作用(溶解角栓、调节角化、抗微生物、抗炎症、减轻皮脂分泌的继发因素等)在药理学上发挥了互补及协同作用，使治疗作用更全面、深入，疗效更满意。

Drugs covered by this patent

minocycline-hydrochloride (MINOCYCLINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN1528326A
Jurisdiction: CN
Classification: —
Expires: 2004-09-15
Drug substance claim: No
Drug product claim: No
Assignee: INSTITUTE OF DERMATOLOGY CHINESE ACADEMY OF MEDICAL SCIENCES
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.